University of Wisconsin Milwaukee

UWM Digital Commons
Theses and Dissertations

August 2018

Baked and Buzzed: Investigating the Influence of
Co-Use of Cannabis and Alcohol on White Matter
Integrity in Emerging Adults
Natasha E. Wright
University of Wisconsin-Milwaukee

Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Clinical Psychology Commons, and the Neuroscience and Neurobiology Commons
Recommended Citation
Wright, Natasha E., "Baked and Buzzed: Investigating the Influence of Co-Use of Cannabis and Alcohol on White Matter Integrity in
Emerging Adults" (2018). Theses and Dissertations. 1953.
https://dc.uwm.edu/etd/1953

This Dissertation is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations
by an authorized administrator of UWM Digital Commons. For more information, please contact open-access@uwm.edu.

BAKED AND BUZZED: INVESTIGATING THE INFLUENCE OF CO-USE
OF CANNABIS AND ALCOHOL ON WHITE MATTER INTEGRITY
IN EMERGING ADULTS

by

Natasha E. Wright

A Dissertation Submitted in
Partial Fulfillment of the
Requirements for the Degree of

Doctor of Philosophy
in Psychology

at
The University of Wisconsin—Milwaukee
August 2018

ABSTRACT
BAKED AND BUZZED: INVESTIGATING THE INFLUENCE OF CO-USE OF CANNABIS
AND ALCOHOL ON WHITE MATTER INTEGRITY IN EMERGING ADULTS
by
Natasha E. Wright
The University of Wisconsin-Milwaukee, 2018
Under the Supervision of Professor Krista M. Lisdahl
Objective: Growing evidence suggests alcohol and cannabis use independently alter
neural structure and functioning, particularly during sensitive developmental time periods such
as adolescence and emerging adulthood. However, there has been minimal investigation into the
effects co-occurring use of these two substances, despite preliminary evidence of unique acute
and psychopharmacological changes due to using alcohol and cannabis together.
Method: Data drawn from the IDEAA Consortium was utilized to assess white matter
integrity as measured by FreeSurfer’s TRACULA in emerging adults (n=192; 16-27 years old).
Timeline Follow-Back was used to calculate past month cannabis use, alcohol use, co-use days,
binge alcohol episode, and co-use-binge days. The Stroop task was administered and normed
scores were used. Multiple regressions investigated white matter integrity by past month
cannabis, alcohol, and co-use days, controlling for appropriate covariates (e.g., site, gender,
education, length of abstinence). Analyses were run twice, once with alcohol as measured in
standard units and once with binge episodes. Follow-up brain-behavior analyses assessed
whether substance use or tracts that differed significantly by substance use then related to Stroop
performance. Correction for multiple comparisons was conducted using Benjamini and
Hochberg’s (1995) False Discovery Rate correction method.
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Results: Corrected for multiple comparisons, cannabis use was significantly related to
increased mean diffusivity in 12 fronto-limbic and fronto-parietal tracts. Cannabis use also
associated with poorer performance on Stroop word reading. Within the MJ+ALC group,
increased mean diffusivity associated with better Stroop interference performance.
Discussion: The present study found cannabis use was associated with decreased white
matter integrity, as measured by mean diffusivity, across fronto-parietal and fronto-limbic tracts.
These results suggest a robust relationship between cannabis use and white matter integrity in
this neurodevelopmentally sensitive time period. Despite our hypotheses, co-use, alcohol use,
and binge drinking did not significantly predict any measures. Future research should further
investigate the potential independent and interactive affects of these substances on preclinical
and clinical levels. Efforts should be made to inform the public of the likely negative impact of
cannabis on white matter quality.
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Introduction
Adolescents and emerging adults undergo ongoing neurodevelopment, including
structural and functional neuronal changes (Giedd et al., 1996; Gogtay et al., 2004; Shaw et al.,
2008), placing them at increased vulnerability to neurotoxins during this period (for review, see
Bava & Tapert, 2010). Across the United States, almost one in fifteen 12th graders smoke
cannabis daily, while one in four 12th graders have engaged in binge drinking (drinking 5 or
more standard drinks on one drinking occasion) in the past two weeks (Miech, Johnston,
O'Malley, Bachman, & Schulenberg, Patrick, 2017). Further, cannabis use is positively
correlated with alcohol use (Johnston, O'Malley, Bachman, & Schulenberg, 2013) and 23% of
high school seniors report simultaneously using both cannabis and alcohol in the past year, while
15.3% of young adults (age 18-29) report using both substances together in the past year,
(Subbaraman & Kerr, 2015; Terry-McElrath, O'Malley, & Johnston, 2013). Therefore, there is a
great public health need to better understand the neurological consequences of such co-occurring
substance use. This is especially true when considering that both alcohol and cannabis use and
abuse have been found to have a wide range of neurocognitive and neuronal consequences in
adolescents (for review, see Lisdahl, Gilbart, Wright, & Shollenbarger, 2013).
The Developing Brain. Vast neurocognitive changes occur across the lifespan,
particularly in adolescence and emerging adulthood (Gogtay et al., 2004). Improved executive
functioning performance is associated with areas that undergo some of the most substantial
development, including the prefrontal cortex (PFC), as well as through pruning of gray matter
and cortical thinning (Giedd et al., 2015; Shaw et al., 2008) and white matter development
(Gogtay et al., 2004). White matter development tends to follow an inverse ‘U’ shaped
trajectory, with white matter integrity peaking in adolescence and young adulthood (Imperati et
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al., 2011). In general, white matter tends to develop anterior to posterior and centrally to
peripherally, though fronto-temporal tracts develop later in the maturation process (for review,
see Yap et al., 2013). Understanding this neuroplasticity, particularly in regards to white matter,
is key to facilitating healthy brain development in this time period (Spear, 2013). The sum of
these neurodevelopmental and limbic system changes may make adolescents particularly
vulnerable to engaging in risky behaviors as well as the neurotoxic consequences of substance
use (for review, see Bava, Jacobus, Thayer, & Tapert, 2013; Bava & Tapert, 2010).
Endocannabinoid System, Cannabis & Alcohol. The main psychoactive component of
cannabis, delta-9-tetrahydrocannabinol (THC), directly binds to cannabinoid receptor 1 (CB1) in
cortical, limbic, and striatal regions (Sim-Selley, 2003). It is notable that the endogenous
cannabinoid (eCB) system plays a role in neurodevelopment. The eCB system contains two
endocannabinoids, arachidonoyl-ethanolamine (anandamide; AEA) and 2-arachidonoyl-glycerol
(2-AG), which can activate CB1 (for review, see Breivogel & Sim-Selley, 2009). Cannabinoid
receptors are located on glutamergic and GABAergic neurons, among others (Alger, 2012).
Endocannabinoids act as neuromodulators; after being activated postsynaptically, they bind to
CB1 receptors in the presynaptic terminal, which in turn prevent neurotransmitter release (see
Hillard, 2015). The eCB system also undergoes neuromaturation in adolescence and emerging
adulthood, making it more vulnerable to exogenous cannabinoids and their deleterious effects on
the eCB system, morphological changes, and overall functioning (for review, see Schneider,
2008).
Chronic cannabis use in young adults has been found to downregulate CB1 receptors in
cortical and limbic regions, but this appears to be reversible with a month of abstinence in
humans (Hirvonen et al., 2012). Alcohol also moderates CB1 receptor activity through
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interacting with neurotransmitters (e.g., glutamate, GABA), with the CB1 receptors in turn
modulating dopamine and GABA receptors, particularly in reward and limbic regions (Pava &
Woodward, 2012). Acutely, alcohol consumption in rats has been found to result in a greater
release of endocannabinoids while, at times, also inhibiting eCB signaling (Rubio, McHugh,
Fernandez-Ruiz, Bradshaw, & Walker, 2007). More chronic alcohol use, though, has been linked
to reduction of CB1 levels in an irreversible manner in humans (Hirvonen et al., 2013).
As cannabis and alcohol both act on the same reward pathways, modulate similar
neurotransmitter and ligand levels (e.g., GABA, dopamine, AEA, 2-AG; see Basavarajappa &
Hungund, 2002; Cruz, Bajo, Schweitzer, & Roberto, 2008), and both downregulate eCB receptor
activity (e.g., CB1), it may logically follow that there is potential for an additive or even
synergistic effect when the two substances are used together. Indeed, the underlying mechanisms
are similar enough that priming with one of these substances prior to use of the other substance,
and vice-versa, has been shown to develop some level of cross-tolerance to either substance (for
review, see Pava & Woodward, 2012). However, differences in these mechanisms also exist,
alcohol stimulates GABA, while cannabinoids inhibit GABA transmission (Cruz et al., 2008).
Pharmacologically, when looking at factors such as blood alcohol content (BAC), co-use of these
substances may interact in such a way that they actually reduce BAC, as THC may slow alcohol
absorption (Lukas et al., 1992). However, this may not always be the case; for example, Chesher
and colleagues (1976) found BAC was increased when alcohol and THC were simultaneously
administered in capsules. Ballard and de Wit (Ballard & de Wit, 2011), in contrast, found no
pharmacokinetic difference when low doses of ethanol and capsule THC were administered in
humans. When cannabis is used in combination with alcohol, plasma and blood THC levels
increase (Hartman et al., 2015; Lukas & Orozco, 2001) and heart rate, a correlate of THC
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absorption, remains higher (Ronen et al., 2010). Cannabinoids may also potentiate the
deleterious effects of alcohol, as found in rodent youths through priming for apoptosis (Hansen
et al., 2008). Therefore, chronic use of alcohol or cannabis in adolescent and emerging adult
years may disrupt the role the eCB system plays in healthy neurodevelopment. However, there is
currently too little evidence to be able to fully understand alcohol and cannabis co-use on
neuropharmacology and their underlying mechanisms.
Co-Use of Cannabis and Alcohol. On a behavioral level, co-occurring use of alcohol and
cannabis has generally been found to be linked to poorer outcomes, such as poorer treatment
outcomes, higher rates of depression, and higher positive expectancies of use and, in turn,
increased use of any substances (Aharonovich et al., 2005; Lopez-Quintero et al., 2011). One
possible reason for these poorer outcomes is that combined use has been related to greater
neurocognitive deficits. Studies examining the acute administration effects of cannabis and
alcohol often suggest an additive effect on cognition, attention, memory, and motor functioning
(Belgrave et al., 1979; Chait & Perry, 1994; Chesher, Franks, Jackson, Starmer, & Teo, 1977;
Marks & MacAvoy, 1989), though not always (Ballard & de Wit, 2011; Bramness, Khiabani, &
Morland, 2010; Ramaekers et al., 2011). Notably, almost all acute administration studies use
very low doses of THC (1.3-3.0%; with the exception of Ramaekers et al., 2011), who used 11%
THC), which may limit generalizability to contemporary doses of cannabis as found in the
general population (averaging 12% THC; ElSohly et al., 2016).
Diffusion Tensor Imaging & White Matter Integrity. A common marker of brain health
and function, as well as a key neurodevelopmental measure in emerging adulthood (Giedd, 2004;
Gogtay et al., 2004), is the diffusion of water across white matter tracts in diffusion tensor
imaging (DTI) (Basser, James, & LeBihan, 1994; Le Bihan, 2003). Such diffusion of water
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indicates differences in neuromicrostructural integrity and architecture, and may be indicative of
neural damage before other measures of brain health (e.g., volumetric analyses in gray matter;
Soares, Marques, Alves, & Sousa, 2013). Healthy oligodendrocyte, and therefore white matter,
development requires CB1 receptors protect progenitors from apoptosis (Molina-Holgado et al.,
2002); thus, downregulation of CB1 receptors due to regular cannabis use (Hirvonen et al., 2012)
may disrupt typical white matter development. Similarly, binge-like ethanol use in adolescent
rats has been found to decrease protein levels (myelin basic protein and myelin oligodendrocyte
glycoprotein) related to myelin development (Pascual, Pla, Minarro, & Guerri, 2014). Loss of
axonal proteins, myelin proteins, and enzymes in mice have also been found following chronic
intermittent ethanol exposure (Samantaray et al., 2015). Therefore, cannabis and alcohol may
disrupt healthy white matter development in adolescents and emerging adults.
Effects of Cannabis, Alcohol, and Co-Use on White Matter. In young adult cannabis
users, with few exceptions (Cousijn et al., 2012; Delisi et al., 2006), the majority of studies have
reported poorer white matter integrity in cannabis users in comparison to healthy controls.
Increased mean diffusivity (MD; (Arnone et al., 2008; Gruber, Dahlgren, Sagar, Gonenc, &
Lukas, 2014; Shollenbarger, Price, Wieser, & Lisdahl, 2015) and decreased fractional anisotropy
(FA; (Arnone et al., 2008; Ashtari et al., 2009; Bava et al., 2009; Clark, Chung, Thatcher, Pajtek,
& Long, 2012; Gruber et al., 2014; Jacobus, Squeglia, Bava, & Tapert, 2013; Shollenbarger,
Price, Wieser, & Lisdahl, 2015) have been found in prefrontal, parietal, cerebellar, corpus
callosum, and temporal regions in regular cannabis emerging adult users.
In studies investigating the effects of alcohol use on WM integrity, a recent meta-analysis
found substance-using adolescents to largely have deficits in white matter microstructure in
neocortical, thalamic, and projection pathways (Baker et al., 2013). With one exception
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(Cardenas et al., 2013), adolescent alcohol users have been found to have reduced white matter
integrity relative to healthy controls in areas such as the corpus callosum, inferior longitudinal
fasciculus (ILF), and superior longitudinal fasciculus (SLF) (Bava et al., 2013; Clark et al., 2012;
Hill, Terwilliger, & McDermott, 2013; Jacobus et al., 2009; Lisdahl, Thayer, et al., 2013;
Luciana, Collins, Muetzel, & Lim, 2013; McQueeny et al., 2009). Adolescent binge drinkers
have also been found to have reduced white matter quality (McQueeny et al., 2009) and smaller
cerebellar volumes (Lisdahl, Thayer, Squeglia, McQueeny, & Tapert, 2013).
Oftentimes cannabis users co-use alcohol, and vice versa. In studies investigating
cannabis and alcohol co-use on WM, conflicting results are found. For example, Jacobus and
colleagues (2013) found co-use to be worse than alcohol use alone as measured by poorer WM
integrity in young adults who were not using substances in their late adolescence but transitioned
into use in early adulthood (ages 19-22). Notably, this study was absent a healthy control group
or a cannabis-only group, and had only 8 individuals per group. Another study (Bava et al.,
2009) investigated WM integrity in 36 cannabis and alcohol users and in 36 healthy controls,
finding 10 clusters with decreased FA and 3 with increased FA in the co-use group. Though they
attempted to investigate the potential influence of cannabis, they did not have a cannabis- or
alcohol-only group, making it difficult to tease apart the unique or even combined contributions
of each substance. In another study, Jacobus and colleagues (2009) concluded that binge-andcannabis users had poorer white matter integrity relative to binge alcohol users alone in a
relatively small sample of 16-19 year olds (n=14 per group). However, the binge-and-cannabis
group drank significantly more in their lifetime, though not in the past three months. Further,
while the binge-and-cannabis group demonstrated better WM integrity than binge alone in some
regions, increased alcohol use was also, at times, related to increased FA values. Together, this
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shows overall aberrant results from what would typically be expected. De Bellis and colleagues
(De Bellis et al., 2008) assessed WM deficits in 32 adolescents (12-18 years old) with an alcohol
use disorder (AUD), 22 of whom also had a cannabis use disorder (CUD), in comparison to 28
healthy controls. The AUD subjects who also had CUD had greater differences in WM integrity;
however, this was characterized by increased FA and decreased MD in the corpus callosum,
which is in the opposite direction as expected and which the authors explained as being evidence
of aberrant maturation of myelination perhaps as a sign of premature aging due to neurotoxicity.
Importantly, the AUD subjects were not screened for psychiatric comorbidities, and even some
of the healthy controls previously met criteria for other disorders, but did not currently meet
diagnostic criteria. In an 18-month longitudinal investigation of 16 to 20 year olds who used any
amount or variety of substances, Bava and colleagues (2013) found differences in WM integrity
between substance users compared to non-users. In follow-up regression analyses, the onset of
alcohol use, but not cannabis use, predicted reductions in white matter integrity in seven clusters:
the left and right SLF, right posterior thalamic radiations, right prefrontal thalamic fibers, right
superior temporal gyrus, right ILF, and the left posterior corona radiata. However, the extensive
use of other illicit-substances confounds the potential to differentiate the relationship between
each particular substance and WM integrity. More recently, Squeglia and colleagues (Squeglia et
al., 2015) found general morphological differences in cannabis-and-alcohol users above and
beyond that found in heavy alcohol-use-alone in comparison to healthy controls a longitudinal
study, with greater attenuation in the medial frontal cortex and insula; however, they also found
larger volumes in the corpus callosum when comparing cannabis-and-alcohol users to heavyalcohol-users alone, leading to equivocal results. Importantly, the controls appropriately had very
limited substance (alcohol or cannabis) use; however, there were no singular (alcohol OR
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cannabis alone) groups, but one co-use (alcohol AND cannabis) group, limiting the ability to
differentiate the influence of each substance. In addition, some participants in the co-use group
had extensive histories of other illicit substance use beyond cannabis use.
In sum, these investigations have begun to tease apart the microstructural implications of
adolescent and emerging adult substance co-use, but have been limited by a number of factors.
Studies thus far have used group analyses rather than assessing dose-dependent relationships or
the potential interactive effects of alcohol and cannabis in co-occurring use episodes. Only one
co-use study (Winward, Hanson, et al., 2014) used an adequate sample, including a cannabisonly group and well-characterized and matched each substance group with the co-use group;
however, this study investigated neurocognition alone, rather than neuroanatomy, and did not
look at patterns of substance use. Studies often only looked at total amount of use or group
status, rather than patterns of use (e.g., estimated number of lifetime uses per substance rather
than the present study’s number of co-occurring use events). Indeed, no known study to date has
investigated patterns of use, which may be an important determinant of effects due to potential
pharmacological differences in co-occurring use (Chesher et al., 1976; Lukas et al., 1992; Lukas
& Orozco, 2001). Therefore, there is a need to have a well-powered analysis of the independent
and interactive effects of cannabis and alcohol, while also investigating the patterns of co-use, on
WM integrity in substance users and controls whose drug use patterns are clearly defined.
Substance Use and Executive Functioning. Executive functioning deficits are a suspected
consequence of substance use in emerging adults (for review, see Lisdahl, Gilbart, et al., 2013).
In regards to cannabis, this is likely due to the high level of CB1 receptors in the prefrontal
cortex (Terry et al., 2009), as frontal regions have been shown to be activated during executive
functioning tasks such as the Stroop task (Egner & Hirsch, 2005). Across adolescence,
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neurodevelopmental changes in healthy adolescents have been linked to performance on a
measure of executive functioning, the Stroop Task (Vijayakumar et al., 2014). Early onset of
marijuana use has been found to be predictive of poorer Stroop performance relative to late onset
use to healthy controls in a number of studies (Gruber, Sagar, Dahlgren, Racine, & Lukas, 2012;
Sagar et al., 2015). Assessing brain-behavior relationships, several studies have also
demonstrated altered functional processing of the Stroop task in MJ users, finding generally
more disparate and diffuse activation in the DLPFC, PFC, and ACC is required for similar
performance attainment (Banich et al., 2007; Gruber & Yurgelun-Todd, 2005; Sagar et al.,
2015). In alcohol, disrupted prefrontal macro- and microstructure is a frequently reported finding
(see Lisdahl, Gilbart, et al., 2013). Dysexecutive performance as measured through the Stroop
task, then, makes logical sense. However, few studies in adolescents and young adults have
found direct links between alcohol consumption and Stroop performance, with other studies
containing null findings despite self-reported daily executive functioning deficits (Gil-Hernandez
& Garcia-Moreno, 2016). Interestingly, one study administered the Stroop task in the fMRI
scanner, finding no performance difference but less activation in the cuneus and precuneus in
alcohol users (Thayer et al., 2015). Greater consideration of the executive functioning deficits
associated with substance use are warranted.
Summary and Aims. Much remains to be discovered regarding co-occurring alcohol and
cannabis use, given the nascent state of the literature. Indeed, even the studies that do exist often
exclude for moderate use—a group that may have distinct qualitative characteristics or
neuroanatomical or neurocognitive effects. However, preliminary studies suggest a potential
additive affect of combined cannabis and alcohol use. CB1 receptor activity is downregulated by
chronic cannabis (Hirvonen et al., 2012) and alcohol use (Hirvonen et al., 2013). Disrupted CB1
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receptor activity may, in turn, affect white matter development, as healthy white matter is
influenced by CB1 activity, and binge-like alcohol use (e.g., (Molina-Holgado et al., 2002;
Pascual et al., 2014; Samantaray et al., 2015). Combined, alcohol and cannabis may have a
cross-tolerance (see Pava & Woodward, 2012), and THC levels may increase while conflicting
studies have shown reduced BAC (Lukas et al., 1992) and increased BAC (Chesher et al., 1976).
A number of studies (Belgrave et al., 1979; Chait & Perry, 1994; Chesher et al., 1977; Marks &
MacAvoy, 1989), though not all (Ballard & de Wit, 2011; Bramness et al., 2010; Ramaekers et
al., 2011), have also found acute additive affects on cognition when the two substances are used
together. Literature on chronic use is more limited. Given the potential for underlying
mechanistic changes that may relate to anatomical and functional changes, more research into the
effects of co-occurring cannabis and alcohol use is needed.
The present study examined structural connectivity in cannabis and alcohol using male
and female adolescents and emerging adults utilizing DTI tractography to assess white matter
integrity with a wide range of substance use patterns. The potential independent effects of
alcohol, cannabis, and cannabis+alcohol co-occurring use on white matter integrity were
assessed. In addition, in order to assess whether structural differences in white matter integrity
between groups relate to functional performance, the relationship between performance on a
neuropsychological task of executive functioning and white matter integrity was examined.
Secondarily, to examine whether larger amounts of alcohol consumed in one episode may have
differential effects, each analysis was repeated with number of binge drinking and MJ+binge
episodes, rather than total alcohol consumed. It was hypothesized that greater recent cannabis
use will predict increased MD and decreased FA in fronto-parietal tracts and fronto-limbic tracts
(specifically, within the uncinate fasciculus; the cingulum angular bundle; the cingulum
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cingulate gyrus; anterior thalamic radiation, or ATR; the corpus callosum forceps major and
forceps minor; the SLF, both parietal and temporal portions; and the ILF; Ashtari et al., 2009;
Clark et al., 2012; Gruber et al., 2014; Jacobus, Squeglia, Bava, et al., 2013; Shollenbarger et al.,
2015). Similarly, it was hypothesized that greater recent drinking will predict increased MD and
decreased FA in these same tracts (Bava et al., 2013; Jacobus et al., 2009). Another primary aim
was to assess the combined effects of alcohol and cannabis co-occurring use on white matter
integrity. Given the attenuation of THC metabolism (Hartman et al., 2015; Lukas & Orozco,
2001; Ronen et al., 2010) and the proposed potentiation of alcohol on THC neurotoxicity
(Hansen et al., 2008), it was predicted that co-occurring MJ and alcohol use would have an
additive effect, such that there would be greater decrements in white matter integrity in frontoparietal and fronto-limbic tracts than alcohol or cannabis use alone. The secondary aim of the
study was to assess brain-behavior relationships, predicting that, in tracts that are significantly
related to alcohol use, cannabis use, or cannabis+alcohol co-use, poorer WM integrity will be
associated with poorer cognitive performance (Anderson, Rabi, Lukas, & Teicher, 2010;
Chanraud et al., 2009; Gruber et al., 2014; Gruber, Silveri, Dahlgren, & Yurgelun-Todd, 2011).
Methods
Overview. The present study analyzed data collected by the Imaging Data in Emerging
Adults Addiction (IDEAA) Consortium (PIs: Krista Lisdahl, Ph.D., UWM site, Staci Gruber,
Ph.D., McLean site, Francesca Filbey, Ph.D., UTD site, and Susan Tapert, Ph.D., UCSD site).
One-hundred and ninety-two participants were included in one combined dataset drawn from the
IDEAA Consortium PI’s individual projects. Data from UCSD, UWM, and McLean were used
in the present study.
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Participants. Data from a total of 192 individuals, aged 16-27, were used for the present
study and although the study focused on dose-dependent effects, participants were classified into
distinct groups for selection of potential covariates (cannabis only, or MJ; alcohol only, or ALC;
cannabis and alcohol co-use, or MJ+ALC; and healthy controls, or HC) and secondary brainbehavior analyses. The Institutional Review Boards at the University of Wisconsin-Milwaukee,
Medical College of Wisconsin, McLean Hospital, and University of California San Diego have
approved all aspects of this study, and all participants provided written informed consent. Groups
were assessed for differences in sociodemographic information, such as gender, age, ethnicity,
and education level. Any significant differences between groups were used as covariates in the
subsequent analyses. Gender was the only variable that differed by substance group and,
therefore, was included as a covariate; in the binge analyses, groups differed on education level
and length of abstinence so these variables were included in those analyses as covariates.
All participants across sites were recruited for participation in a substance use study. For
the current analysis, the following group definitions were used. MJ Criteria: MJ participants used
at least half a gram of cannabis a week, on average, over the past month. They used less than 20
standards drinks of alcohol in the past month. ALC Criteria: ALC participants drank at least 20
standard drinks on average over the past month and used less than half a gram of cannabis a
week. MJ+ALC Criteria: MJ+ALC participants exhibited patterns of regular substance use
averaged over the past month (consuming =/> 20 standard drinks a month, use cannabis =/>0.5
gram a week). HC Criteria: Controls used less than 20 standards drinks of alcohol in the past
month and less half a gram of cannabis per week on average over the last month.
Exclusion Criteria for All Participants: Current use of psychotropic medication, lifetime
history of serious neurologic injuries or disorders, major medical illness, diagnosis of an
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independent Axis I psychiatric disorder in past year (except for Substance Abuse or Dependence
in any of the substance using groups), pregnancy, or MRI contraindications (e.g., metal
anywhere in or on the body, greater than 250 lbs, claustrophobia). McLean allowed for lefthandedness, and, therefore, three left-handed participants were included; all other sites excluded
for left-handedness. Alcohol and breathalyzer screens verified .000 breath alcohol concentration
at all study sessions. For McLean site only, recent binge drinking (defined as 4 or more drinks
for a female, 5 or more drinks for a male, within a 2 hour period) was an exclusion criteria;
therefore, McLean’s participants were excluded from any binge-specific analyses.
Procedure. Eligible participants completed each respective parent study protocol and
were asked to come to the MRI scanning center at each of the respective institutions. They were
asked to remain abstinent from all substance use other than cigarettes for a minimum of 12 hours
prior to session start. Participants were given breathalyzer and toxicology tests. UCSD and
UWM also collected pregnancy tests for females; McLean Hospital relied on subject self-report
of pregnancy. Positive results on either the pregnancy (when used) or breathalyzer tests regarded
participants as ineligible, and they were subsequently given small compensation for their time. If
negative, participants were given psychological questionnaires to assess mood and psychological
variables. Participants then completed the neuroimaging and neurocognitive testing protocols.
All participants were compensated for their time.
Recent Drug Use. At all sites, drug use history was collected using the Timeline FollowBack (TLFB; Sobell & Sobell, 1992). Using a calendar to cue special dates and holidays,
participants were asked to recount when they used alcohol (standard drinks), cannabis (grams),
co-occurring alcohol and cannabis (days of co-use). Number of binge drinking episodes (≥4
drinks for females, ≥5 for males in one drinking occasion, not limited by hours) was also
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calculated for UWM and UCSD site participants. Data for past month of use was averaged to the
past month (30 days), as each site collected varying lengths of time. When available, length of
abstinence was calculated (McLean site did not calculate this due to their short, 12 hour, period
of time of required abstinence for participants).
Measures. A different set of neuropsychological measures were administered at each site;
however, each used a version of the Stroop task (e.g., Comalli Stroop; Comalli, Wapner, &
Werner, 1962), which is used in the present analyses. UWM and UCSD both administered the DKEFS Color-Word Interference Task (Delis, Kaplan, & Kramer, 2001). It consists of four
subtests: a word reading list, a color naming list, a color-word list, and a color-word+word
reading list. Time to complete each condition was measured. Only the first three subtests are
included in the proposed study to better match the other sites. McLean Hospital utilized the
Comalli Stroop (Comalli et al., 1962), which allows a set amount of time to read and/or name as
many words/colors as possible; total number of words/colors read was measured. Total reading
score, total color naming score, and total color-word interference score were calculated. Each
subject’s performance was converted to the correct version’s normed scores. It was then
converted to a z-score, allowing for comparison across sites and versions.
MRI Data Acquisition. Each site used a standardized acquisition protocol on its
respective 3T scanner (GE, Siemens, or Phillips). See Table 1 for specific structural acquisition
parameters by site.
Diffusion Tensor (DTI) Image Acquisition. Diffusion Tensor Imaging (DTI) was
similarly obtained standardized protocols at each site (see Table 2). Raw DTI data was then
uploaded to the IDEAA server pre-processed all DTI data by the UWM site in order to ensure
consistency and all DTI datasets underwent the same exact preprocessing pipeline on the same
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computer system using a script capable of handling data from multiple scanner platforms. All
structural data, including tracts of WM through FreeSurfer’s Tracks Constrained by Underlying
Neuroantomy (TRACULA), was processed by UWM, again to ensure consistency across
datasets.
DTI Processing. FreeSurfer software was used to pre-process all T1-weighted 3D
anatomical datasets, correcting for motion, non-parametric non-uniform intensity normalization,
MNI transformation, removal of non-brain material, and skull-stripping. Whole-brain
segmentation of white and gray matter was then completed. TRACULA (a software program
within FreeSurfer) was then used to reconstruct white matter pathway from DTI images using a
global probabilistic tractography program. This yields measures of white matter integrity,
including fractional anisotropy (FA) and mean diffusivity (MD) (Yendiki et al., 2011). Each
image underwent the following preprocessing steps: (1) Image Corrections (e.g., for B0
inhomogeneities, eddy currents, and simple head motion), (2) Further head motion correction, (3)
Intra-subject and Inter-subject registration (4) Mask creation (white matter is extracted from
FreeSurfer’s segmentation and parcellation and combined into a mask), (5) Tensor fit, and (6)
Estimation of pathways by combining the individual’s data with an atlas. Following
preprocessing, a ball-and-stick model of diffusion was fitted to the images. Markov Chain Monte
Carlo sampling was used to measure diffusion in each voxel, then establishing the likelihood of
locations of tract for each subject. From these estimated pathways, statistics on diffusion
measures (average weighted FA and MD) within each individual were extracted and exported
into SPSS for regression analysis. Correction for multiple comparisons was conducted using
Benjamini and Hochberg’s (1995) False Discovery Rate (FDR) correction method.
Data Analysis. All analyses were conducted in SPSS.
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Preliminary Analyses. Although the primary analyses used dose-dependent independent
variables, differences in demographic data and psychological indices were examined with
ANOVA and chi-square analyses between groups (gender, age, education, race, ethnicity,
handedness). Variables that differentiated the groups were included in subsequent analyses as
covariates, along with study site; gender was the only variable that differed by group and
therefore was include in each analysis for all participants. When investigating analyses by group
with only binge data, length of abstinence and education differed, and so were included in all
binge analyses.
Primary Analyses. A series of multiple regressions (FA and MD of specific hypothesized
tracts) examined the study aims. For the first primary analysis (N=192), the independent
variables included: past month drinking (standard drinks), past month cannabis (total grams), and
co-occurring alcohol-cannabis smoking days. Covariates included study site and important
demographics that may differ by group (i.e., gender). Next, the influence of binging was assessed
by including past month binge episodes, past month cannabis, and number of co-occurring
binge-cannabis days, and included covariates (i.e., study site, length of abstinence, and
education) (N=134). All regression analyses were corrected for multiple comparisons by the
FDR method (Benjamini & Hochberg, 1995).
Secondary Analyses. For secondary analyses, 167 of the 192 participants completed a
version of the Stroop task. To assess brain-behavior relationship, multiple regressions were run,
assessing whether differences in white matter integrity predict performance on a
neuropsychological task of executive functioning, controlling for study site. As sites varied in
versions of measures administered, each subject’s normed performance on a task was
transformed into a z-score. This was then used in all statistical analyses. Analyses were
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completed by substance use group, to ensure that no significant differences would be obscured if
relationships were in opposing directions.
In addition, the relationship between past month substance use and Stroop performance
was examined. First, total past month alcohol (standard drinks; 1 ounce of liquor, 4 ounces of
wine, 12 ounces of beer), cannabis (grams), and co-occurring alcohol-cannabis smoking days
were investigated to see if they were associated with Stroop performance, when controlling for
covariates. Next, past month binging episodes (number of binge drinking episodes; ≥4 drinks for
females, ≥5 for males in one drinking occasion, not limited by hours), cannabis (grams), and cooccurring binging-cannabis episodes (co-occurring alcohol and cannabis, days of co-use-binge;
binging defined as ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by
hours), along with appropriate covariates, were investigated to see if they were associated with
Stroop performance.

Results
Demographics. Participants were recruited from different regions of the United States (59
from the West Coast; 75 from the Midwest; 58 from the East Coast). When including all three
sites, groups significantly differed by gender (F(187)=3.49, p=.02); no other demographic
variables were significantly associated with group status. When investigating analyses by group
with only binge data (UWM and UCSD), length of abstinence (F(121)=2.82, p=.04) and
education (F(130)=2.73, p=.05) differed, and so were included in all binge analyses.
In addition, participants were divided between those who had (CO) and had not (NO)
used alcohol and cannabis on the same day in the past month, though these groups were used in
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no analyses and were assessed strictly for descriptive purposes. They did not differ in age,
education, gender, ethnicity, race, or handedness.
Substance Use Patterns. Participants exhibited a wide range of substance use in the past
month (alcohol standard drinks: mean=19.68, SD=26.75, range=0-167.14; cannabis use in
grams: mean=8.33, SD=18.14, range=0-139.91; number of binge episodes: mean=1.36,
SD=2.85, range=0-15; see Table 5). Substance use differed significantly by group in past month
cannabis use [F(187)=30.67, p<.001], alcohol use [F(187)=80.95, p<.001], binge episodes
[F(187)=27.40, p<.001], co-use episodes [F(179)=89.03, p<.001], and co-use-binge episodes
[F(184)=27.73, p<.001]. As expected, the ALC and MJ+ALC groups had significantly more past
month alcohol use and binge episodes than either the MJ or HC groups while the MJ and
MJ+ALC groups had significantly more past month cannabis use than the ALC or HC groups.
For co-use and co-use-binge episodes, the MJ+ALC group had significantly more of each
episode than the HC, MJ, or ALC groups. In addition, the MJ group had significantly more couse episodes than the HC, though did not differ significantly from the ALC group.
In investigating co-use compared to no co-use, co-use groups differed significantly with
past month substance use as exhibited by greater past month cannabis [F(181)=59.92, p<.001],
alcohol [F(181)=56.69, p<.001], binge episodes [F(181)=38.84, p<.001], co-use episodes
[F(181)=140.78, p<.001], and co-use-binge episodes [F(181)=50.97, p<.001] in the CO group
(see Table 6). Groups also differed in maximum alcohol [F(129)=7.71, p<.01] and maximum
cannabis use [F(132)=76.05, p<.001] in the past month in one episode, number of drinking days
[F(180)=25.71, p<.001] and number of smoking days per month [F(131)=130.17, p<.001],
average grams per smoking day in the past month [F(131)=119.10, p<.001]. However, CO v. NO
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groups did not significantly differ on average drinks per drinking day in the past month
[F(131)=2.22, p=.14].
Correlational analyses were run between past month substance use patterns. All substance
use variables (alcohol use, cannabis use, binge episodes, co-use episodes, and co-use-binge
episodes) were significantly correlated except past month binge episodes and past month
cannabis use (see Table 7).
Study Site. As study site is a significant predictor of most variables (see below), an effort
was made to better understand specific site characteristics. Importantly, prior research has
established the reliability of combining data across multiple sites so long as site is a covariate
(Pagani et al., 2010; Fox et al., 2012; Magnotta et al., 2012). Demographics by site are listed in
Table 8. When assessing for demographic differences by study site, age [F(188)=45.79, p<.001],
education [F(189)=69.83, p<.001], race [x2=23.15, p=.01], and ethnicity [x2=13.86, p=.01]
significantly differed. When the whole-sample is assessed together by substance group, there is
no longer a statistically significant difference in these variables (see Demographics section
above).
Quantitative values of white matter integrity by Study Site were also pulled to see if there
was any clear pattern (see Appendix I). In FA values, there was no clear pattern of better quality
WM by site, as each site occasionally had higher FA values depending on the tract. In MD
values, there was no clear pattern between UWM and McLean, but UCSD generally had a lower
MD value.
In addition, group differences were assessed within each site. No significant differences
by group were found within any of the sites. The one exception to this was in McLean’s data,
with gender being significantly different by group (F(42)=5.74, p<.01). This is consistent with
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the broader findings of the whole combined sample, and is accounted for by covarying for
gender in all whole-sample analyses.
Differences by study site were also found in substance use patterns (see Table 9). Sites
differed in cannabis use [F(189)=9.64, p<.001], as McLean participants had significantly more
past month cannabis use (in grams) than UWM or UCSD.
Primary Analysis: TRACULA.
Co-Use Data.
FA. Primary Predictors (see Table 10). Past month cannabis use was significantly
associated with decreased FA in the following tracts: forceps minor [beta=.18, t=2.16, p=.03,
FDR-p=.13], left ILF [beta=.21, t=2.41, p=.02, FDR-p=.13], left uncinate [beta=.22, t=2.57,
p=.01, FDR-p=.13], and right SLF temporal [beta=-.19, t=-2.18, p=.03, FDR-p=.13], though no
tracts survived correction for multiple comparisons. Neither past month alcohol or co-use were
significantly associated FA in any tract.
Covariates. Study site was significantly associated with forceps major [beta=.25, t=3.35,
p<.01, FDR-p<.01], forceps minor [beta=.23, t=3.25, p<.01, FDR-p<.01], left ILF [beta-.24, t=3.26, p<.01, FDR-p<.01], left uncinate [beta=-.21, t=-2.99, p<.01, FDR-p<.01], left ATR
[beta=.30, t=4.22, p<.001, FDR-p<.001], right ATR [beta=.47, t=7.15, p<.001, FDR-p<.001],
left cingulum angular bundle [beta=-.24, t=-3.32, p<.01, FDR-p<.01], right cingulum angular
bundle [beta=-.31, t=-4.26, p<.001, FDR-p<.001], left cingulum cingulate gyrus [beta=-.22, t=3.04, p<.01, FDR-p<.01], right cingulum cingulate gyrus [beta=-.30, t=-4.07, p<.001, FDRp<.001], left SLF parietal [beta=-.23, t=-3.14, p<.01, FDR-p<.01], right SLF parietal [beta=-.30,
t=-4.11, p<.001, FDR-p<.001], left SLF temporal [beta=-.21, t=-2.93, p<.01, FDR-p<.01].
Gender was significantly associated with left uncinate [beta=-.24, t=-3.53, p<.01, FDR-p=.02].
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Prior to correction for multiple comparisons, gender was also significantly associated
with right uncinate [beta=-.14, t=-1.80, p=.07, FDR-p=.39] and left ATR [beta=-.14, t=-2.05,
p=.04, FDR-p=.34]. In each of these instances, males exhibited higher FA compared to females.
MD. Primary Predictors (see Table 11). After correcting for multiple comparisons, past
month cannabis use was significantly associated with increased MD in forceps major [beta=.14,
t=2.18, p=.03, FDR-p=.04], left ILF [beta=.14, t=2.49, p=.014, FDR-p=.03], right ILF [beta=.15,
t=2.70, p<.01, FDR-p=.02], right uncinate [beta=.16, t=2.39, p=.02, FDR-p=.03], left ATR
[beta=.19, t=2.61, p=.01, FDR-p=.02], right ATR [beta=.17, t=2.41, p=.02, FDR-p=.03], left
cingulum angular bundle [beta=16, t=2.15, p=.03, FDR-p=.04], right cingulum angular bundle
[beta=.18, t=2.32, p=.02, FDR-p=.03], left cingulum cingulate gyrus [beta=.22, t=-2.80, p<.01,
FDR-p=.02], right cingulum cingulate gyrus [beta=.19, t=2.32, p=.02, FDR-p=.03], left SLF
parietal [beta=.20, t=2.87, p=.01, FDR-p=.02], right SLF parietal [beta=.22, t=3.33, p<.01, FDRp=.01], left SLF temporal [beta=.20, t=3.04, p<.01, FDR-p<.02], right SLF temporal [beta=.21,
t=3.28, p<.02, FDR-p=.01]. Neither past month alcohol or co-use were significantly associated
with MD in any tract.
Covariates. Study site was significantly associated with forceps major [beta=-.66, t=11.73, p<.001, FDR-p<.001], forceps minor [beta=-.76, t=-15.81, p<.001, FDR-p<.001], left ILF
[beta=-.76, t=-15.48, p<.001, FDR-p<.001], right ILF [beta=-.78, t=-16.60, p<.001, FDRp<.001], left uncinate [beta=-.63, t=-11.18, p<.001, FDR-p<.001], right uncinate [beta=-.64, t=11.18, p<.001, FDR-p<.001] , left ATR [beta=-.57, t=-0.37, p<.001, FDR-p<.001], right ATR
[beta=-.56, t=-9.15, p<.001, FDR-p<.001], left cingulum angular bundle [beta=-.52, t=-8.15,
p<.001, FDR-p<.001], right cingulum angular bundle [beta=-.51, t=-7.93, p<.001, FDR-p<.001],
left cingulum cingulate gyrus [beta=-.41, t=-6.06, p<.001, FDR-p<.001], right cingulum
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cingulate gyrus [beta=-.38, t=-5.47, p<.001, FDR-p<.001], left SLF parietal [beta=-.60, t=-9.95,
p<.001, FDR-p<.001], right SLF parietal [beta=-.65, t=-11.54, p<.001, FDR-p<.001], left SLF
temporal [beta=-.65, t=11.61, p<.001, FDR-p<.001], and right SLF temporal [beta=-.69, t=12.96, p<.001, FDR-p<.001].
Gender was significantly associated with left uncinate [beta=.12, t=2.07, p=.04, FDRp=.64] prior to correction for multiple comparisons.
Co-Use-Binge Data.
FA. Primary Predictors (see Table 12). Past month cannabis use was significantly
associated with decreased FA in the right cingulum angular bundle prior to correction for
multiple comparisons [beta=-.28, t=-2.47, p=.02, FDR-p=.24]. Neither past month binge or couse-binge were significantly associated with FA in any tract.
Covariates. Study site was significantly associated with forceps major [beta=.31, t=2.25,
p=.03, FDR-p=.05], forceps minor [beta=.44, t=3.23, p<.01, FDR-p<.01], left ILF [beta-.36, t=2.71, p=.01, FDR-p=.02], left ATR [beta=.45, t=3.40, p<.01, FDR-p<.01], right ATR [beta=.67,
t=6.18, p<.001, FDR-p<.01], left cingulum angular bundle [beta=-.38, t=-2.73, p=.01, FDRp=.02], right cingulum angular bundle [beta=-.43, t=-3.28, p<.01, FDR-p<.01], left cingulum
cingulate gyrus [beta=-.31, t=-2.19, p=.03, FDR-p=.05], right cingulum cingulate gyrus [beta=.53, t=-3.99, p<.001, FDR-p<.01], left SLF parietal [beta=-.29, t=-2.10, p=.04, FDR-p=.05], right
SLF parietal [beta=-.45, t=-3.33, p<.01, FDR-p<.01], and left SLF temporal [beta=-.30, t=-2.16,
p=.03, FDR-p=.05].
MD. Primary Predictors (see Table 13). After correcting for multiple comparisons, past
month cannabis use was significantly associated with increased MD in the right SLF temporal
[beta=.11, t=3.29, p<.01, FDR-p=.02]. Prior to, but not after, corrections, past month cannabis
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use was significantly associated with left ILF [beta=.09, t=2.20, p=.03, FDR-p=.12], right ILF
[beta=.07, t=2.03, p=.04, FDR-p=.12], right ATR [beta=.076, t=2.031, p=.05, FDR-p=.12], right
SLF parietal [beta=.08, t=2.57, p=.01, FDR-p=.07], left SLF temporal [beta=.12, t=2.51, p=.01,
FDR-p=.07], and right SLF temporal [beta=.11, t=3.29, p<.01, FDR-p=.02].
Past month co-use-binge was significantly associated with decreased MD in the left ILF
[beta=-.11, t=-2.10, p=.04, FDR-p=.15], and right ILF [beta=-.11, t=-2.45, p=.02, FDR-p=.15]
before correction for multiple comparisons.
Covariates. Study site was significantly associated with forceps major [beta=-.81, t=11.68, p<.001, FDR-p<.001], forceps minor [beta=-.82, t=-11.17, p<.001, FDR-p<.001], left ILF
[beta=-.89, t=-19.34, p<.001, FDR-p<.001], right ILF [beta=-.87, t=-22.12, p<.001, FDRp<.001], left uncinate [beta=-.83, t=-14.18, p<.001, FDR-p<.001], right uncinate [beta=-.82, t=16.44, p<.001, FDR-p<.001], left ATR [beta=-.84, t=-18.99, p<.001, FDR-p<.001], right ATR
[beta=-.86 t=-20.05, p<.001, FDR-p<.001], left cingulum angular bundle [beta=-.77, t=-11.43,
p<.001, FDR-p<.001], right cingulum angular bundle [beta=-.72, t=-9.36, p<.001, FDR-p<.001],
left cingulum cingulate gyrus [beta=-.82, t=-13.56, p<.001, FDR-p<.001], right cingulum
cingulate gyrus [beta=-.75, t=-11.32, p<.001, FDR-p<.001], left SLF parietal [beta=-.86, t=18.16, p<.001, FDR-p<.001], right SLF parietal [beta=-.87, t=-22.98, p<.001, FDR-p<.001], left
SLF temporal [beta=-.86, t=-17.07, p<.001, FDR-p<.001], and right SLF temporal [beta=-.86,
t=-21.90, p<.001, FDR-p<.001].
Education was significantly associated with right ILF [beta=.09, t=2.18, p=.03, FDRp=.07], right uncinate [beta=.14, t=2.77, p=.01, FDR-p=.03], left ATR [beta=.12, t=2.72, p=.01,
FDR-p=.03], right ATR [beta=.11, t=2.54, p=.01, FDR-p=.04], right cingulum cingulate gyrus
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[beta=.16, t=2.43, p=.02, FDR-p=.04], right SLF parietal [beta=.12, t=3.20, p<.01, FDR-p=.03],
and right SLF temporal [beta=.11, t=2.80, p=.01, FDR-p=.03].
Prior to correction for multiple comparisons, length of abstinence was significantly
associated with left cingulum cingulate gyrus [beta=.08, t=-1.81, p=.07, FDR-p=.24], right
Cingulum Cingulate [beta=.09, t=1.90, p=.06, FDR-p=.24], right SLF parietal [beta=.07, t=2.66,
p=.01, FDR-p=.14], and right SLF temporal [beta=.06, t=2.38, p=.02, FDR-p=.15].
Secondary Analysis: DTI-Stroop.
Co-Use Data.
Stroop. Within the MJ+ALC group, multiple regression analyses revealed significant
positive relationships between MD tracts and Stroop performance, after correcting for multiple
comparisons. Specifically, forceps major [beta=.54, t=2.72, p=.01, FDR-p=.02], left ILF
[beta=.51, t=2.54, p=.02, FDR-p=.02], right ILF [beta=.61, t=2.59, p=.01, FDR-p=.02], right
uncinate [beta=.49, t=2.58, p=.01, FDR-p=.02], left ATR [beta=.48, t=2.65, p=.01, FDR-p=.02],
right ATR [beta=.45, t=2.47, p=.02, FDR-p=.02], left cingulum angular bundle [beta=.38,
t=2.17, p=.04, FDR-p=.04], right cingulum angular bundle [beta=.39, t=2.28, p=.03, FDRp=.03], left cingulum cingulate gyrus [beta=.44, t=2.78, p=.01, FDR-p=.02], right cingulum
cingulate gyrus [beta=.42, t=2.60, p=.01, FDR-p=.02], left SLF parietal [beta=.49, t=2.82, p=.01,
FDR-p=.02], right SLF parietal [beta=.48, t=2.41, p=.02, FDR-p=.03], left SLF temporal
[beta=.49, t=2.64, p=.01, FDR-p=.02], and right SLF temporal [beta=.50, t=2.45, p=.02, FDRp=.02] were significantly associated with better Stroop color-word interference performance. No
other groups revealed significant relationships between tracts and Stroop performance.
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Co-Use-Binge Data.
Multiple regressions were run by group, controlling for study site, to assess whether the
one tract that was associated with cannabis use (right SLF temporal MD) significantly related to
Stroop performance. No significant results were revealed.
Secondary Analysis: Substance Use Patterns-Stroop.
Co-Use Data.
Word reading performance was significantly negatively related to past month cannabis
use [beta=-.23, t=-2.64, p=.01], and marginally positively related to by past month alcohol use
[beta=.177, t=1.97, p=.05]. Color naming and color-word interference were not significantly
associated with any primary predictors.
Co-Use-Binge Data.
Color naming, word reading, and color-word interference were not related to any primary
variables.

Discussion
The present study found a number of significant and robust relationships between past
month cannabis use and poorer white matter integrity (measured by increased MD). However,
contrary to our hypotheses, we did not see any influence of co-use episodes, past month alcohol
use, past month binge episodes, or co-use-binge episodes. Secondary brain-behavior
relationships were assessed, finding that, within only the MJ+ALC group, increased MD was
positively associated with Stroop performance on the color-word interference subtest. Finally,
analyses assessed the influence of substance use on Stroop performance, finding again that
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cannabis use was the only substance significantly associated with word reading when assessed in
the whole sample.
Consistent with prior findings in adolescent and emerging adult MJ users (Arnone et al.,
2008; Ashtari et al., 2009; Gruber et al., 2014; Shollenbarger et al., 2015), we found increased
MD was associated with past month cannabis use. Our findings are consistent and robust across
fronto-limbic and fronto-parietal networks (specifically, within the uncinate fasciculus; the
cingulum angular bundle; the cingulum cingulate gyrus; anterior thalamic radiation; the corpus
callosum forceps major and forceps minor; the SLF, both parietal and temporal portions; and the
ILF tracts). Such disrupted WM may be indicative of damage to myelination due to cannabis use
during this sensitive neurodevelopmental time period. Indeed, MJ use downregulates CB1
activity (Hirvonen et al., 2012) and cannabinoid receptors are important for WM development
(Molina-Holgado et al., 2002), suggesting a potential underlying mechanism of these findings.
This increased MD is likely an indication of altered processing that can be broken down
by pathway types. It is interesting to hypothesize about potential functional implications of
structural differences, though the present study assessed only one specific function. First, the
association tracts (SLF, ILF, uncinate fasciculus, and the cingulum) connect distant regions
within the same hemisphere and are involved in key functions such as higher cognitions, emotion
regulation, memory, and visuospatial processing (Catani & Thiebaut de Schotten, 2012; Hua et
al., 2009). The SLF connects the frontal, parietal, and temporal lobes, and is generally involved
in language, visuospatial skills, and working memory. The ILF connects the occipital and
temporal lobes, the amygdala, and the hippocampus, and is involved in functions such as
perception, visual memory, and aspects of language. The uncinate fasciculus connection the
anterior temporal lobe with the orbitofrontal cortex and is key to the function of the limbic
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system. The cingulum connects the frontal, parietal, temporal, and occipital lobes to different
portions of the cingulate cortex, leading to the limbic system and functions such as attention,
memory, and emotion. As many of these pathways relate to fronto-limbic and cognitive
functioning, increased dysexecutive symptoms and poorer mood regulation may be expected.
Indeed, this is what is commonly seen in the cannabis literature; specifically, in MJ users, our
group previously found poorer WM integrity in the bilateral uncinate to be predictive of
increased mood and apathy symptoms (Shollenbarger et al., 2015). Others have similarly found
cannabis users to have either decreased WM integrity in association tracts (Arnone et al., 2008;
Ashtari et al., 2009; Delisi et al., 2006), or deficits in cognitive (Lisdahl & Price, 2012; Solowij
et al., 2011) or emotional (McQueeny et al., 2011; Wright, Scerpella, & Lisdahl, 2016)
functioning, or both structural and functional deficits (Maple et al., under review; Gruber et al.,
2014; Gruber et al., 2011). Admittedly, the present study did not find this relationship with
executive functioning due directly to substance use. As this was a single measure in a secondary
analysis, a more thorough neuropsychological battery may have revealed such relationships.
The commissure pathways connect the two hemispheres through the corpus callosum and
here are divided between the corpus callosum forceps major and forceps minor (Catani &
Thiebaut de Schotten, 2012). The forceps minor encompasses the genu and rostrum, within the
PFC and OFC respectively. The forceps major includes the splenium in the occipital cortex, with
some fibers reaching the parietal and temporal lobes (Catani & Thiebaut de Schotten, 2012). Our
group (Shollenbarger et al., 2015) and others (Gruber et al., 2014) previously found increased
MD in the forceps minor and anterior portions of the corpus callosum in cannabis users, though
the present study did not find any results related to the forceps minor. More consistent with the
present findings, Bava and colleagues (Bava et al., 2009) found poorer WM integrity in the
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splenium in MJ+ALC users relative to controls, while Jacobus, Squeglia et al. (Jacobus,
Squeglia, Bava, et al., 2013) found decreased WM in the splenium in both heavy drinkers and
heavy drinkers-and-MJ users relative to controls. Given the role of the forceps major in
visuospatial processing and deficits in visuospatial processing with disrupted WM in this region
(Lunven et al., 2015) and other research suggesting disrupted visuospatial skills in MJ users
(Huestuegge et al., 2002; Smith et al., 2010), future research should more directly assess
potential brain-behavior relationships with the forceps major in substance using populations.
The projection pathways connect cortical and subcortical regions, allowing for
communication of sensory and motor information (Catani & Thiebaut de Schotten, 2012). Here
we found cannabis use was related to increased MD in the bilateral ATR, a region key for limbic
functions and communication between the thalamus and PFC. Similarly, Becker and colleagues
(2015) found young adult heavy cannabis users had reduced WM growth in a range of projection
and other pathways over a three year period, relative to controls, and that this reduced growth
was predictive of poorer verbal learning performance. Here again, then, it is suggested that
underlying microstructural integrity may be altered by cannabis use, and, while not seen in the
present study, such microstructural changes may lead to functional impairment.
Interestingly and contrasting our hypotheses, FA was not significantly related to
substance use patterns. Unlike others (Ashtari et al., 2009; Delisi et al., 2006; Gruber et al., 2014;
Shollenbarger et al., 2015) we did not find differences in FA by MJ use. FA is known to be a
sensitive measure of overall microstructural integrity in WM as measured through directional
cohesion, but does not offer much information related to type of change (Alexander et al., 2007).
In contrast, MD measures the diffusion rate and free diffusion (Soares et al., 2013). Previously,
our group has found MD to be particularly sensitive in MJ users (Shollenbarger et al., 2015), and
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others have suggested MD is also a more sensitive measure in other clinical samples (e.g., in
epilepsy patients; Kreilkamp, Weber, Richardson, & Keller, 2017). Perhaps MJ damages WM
microstructure in specific ways that are lost when looking at an overall value, such as FA.
Also contrary to our hypotheses, we did not find any significant relationships between
alcohol use and white matter integrity, despite previous findings (Cardenas et al., 2013; De Bellis
et al., 2008; Lisdahl, Thayer, et al., 2013; Luciana et al., 2013; McQueeny et al., 2009; Squeglia
et al., 2015). Further, the lack of findings around binging and co-use-binge episodes may initially
be surprising given prior studies (Lisdahl, Thayer, et al., 2013; McQueeny et al., 2009).
However, given the limited amount of co-use-binge in the sample (mean=1.77 in the past
month), there may not have been enough variance to detect real change based on limited use.
Other studies have also found results to be more robust when investigating MJ use rather than by
alcohol use (Lisdahl & Price, 2012; Wright et al., 2016), perhaps indicating MJ is a more reliable
predictor of such deficits. This does not negate the importance of measuring alcohol use and such
findings as these are not always the case (e.g., Jacobus, Squeglia, Bava, et al., 2013; Lisdahl,
Thayer, et al., 2013), but underscores the need to measure cannabis and alcohol use with careful
quantitative techniques that enable assessment of the unique influence of each substance.
Co-use episodes, whether or not considering alcohol binges, were not significantly
related to any DTI outcomes once we corrected for multiple comparisons. This is in contrast to
our expectations and to other studies that have shown acute additive cognitive deficits (Belgrave
et al., 1979; Chait & Perry, 1994; Chesher et al., 1977; Marks & MacAvoy, 1989) and chronic
cognitive deficits due to co-use (Winward, Hanson, et al., 2014), though none of these studies
investigated WM differences. Given the somewhat equivocal results of human pharmacological
studies (Chesher et al., 1976; Hartman et al., 2015; Lukas et al., 1992; Lukas & Orozco, 2001)
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and even acute (Raemakers et al., 2011) and chronic studies (Mahmood et al., 2010), this may
not be a surprising finding. Acutely, alcohol may increase endocannabinoid levels (AlvarezJaimes, Stouffer, & Parsons, 2009; Rubio, McHugh, Fernandez-Ruiz, Bradshaw, & Walker,
2007), which may offset the effects of MJ, even though chronic alcohol use may downregulate
CB1 activity (Hirvonen et al., 2013). However, the nascent literature of the pharmacological
interactive effects of MJ and alcohol, the preliminary evidence of acute deficits, and the
equivocal findings of chronic effects (as suggested here, and in Winward, Hanson, et al., 2014)
highlight the great need of more research in this area. These studies should consist both of
preclinical work, as well as carefully categorizing and accounting for co-use of substances in
human subjects.
As may be expected, almost all substance use measured was significantly correlated. The
exception to this was between past month number of binge episodes and past month grams of
cannabis used. Substance use groups may then be qualitatively different in how they approach
substance consumption. Subjectively, when cannabis and alcohol are consumed together at low
doses, the alcohol may be prolonging the effects of THC (Hartman et al., 2016); however, this
relationship has not been assessed at a higher dose. Perhaps with larger dosing the effects are less
pleasant, deterring more people from both binging and smoking marijuana together. As
Guttmannova and colleagues suggest (Guttmannova et al., 2016), however, co-use of substances
is a complex topic with many nuanced indicators due to policy and environmental factors,
warranting more research in this area.
Limitations of the current study should be noted. Study site significantly related to most
analyses, although it is notable that prior studies suggest that combining data across different
sites and even scanner brands to be reliable (Fox et al., 2012; Magnotta et al., 2012; Pagani et al.,
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2010), if properly accounted through statistically covarying. The present study was designed
with the intent to broaden external validity, including a range of demographics and substance use
patterns across sites. Inherent in increasing external validity is reduced internal validity. Even so,
results regarding MJ use and WM integrity are very robust, after controlling for study site and
gender. This perhaps suggests the strong influence of cannabis use on WM integrity, despite
differences in population makeup and locale. While every effort was made to carefully measure
the past month of substance use, particularly for assessing same-day substance use, we were not
able to account for whether or not the substances were used simultaneously or even within hours
of one another. Future research should more carefully determine simultaneous use. The present
study did not have consistent tobacco use information across study sites and, therefore, tobacco
use was not accounted for in the present analyses, despite the potential influence of tobacco use
on brain structure and function. Not all sites excluded for learning disabilities, and, therefore,
performance on the Stroop task may have been influenced by potential inclusion of individuals
with a learning disability. While brain-behavior analyses were initially examined, we only used a
single neurocognitive task, despite the range of cognitive deficits that may be affected by
cannabis or alcohol use; future studies should include a full neuropsychological battery. Finally
as a cross-sectional study, causal relationships cannot be established; future studies, such as the
Adolescent Brain and Cognitive Development (ABCD) study, are needed to assess causality.
Conclusion. In conclusion, the present study found that greater past month cannabis use
was associated with decreased WM integrity, as measured by MD, across fronto-parietal and
fronto-limbic tracts. These robust findings suggest abnormal WM quality related to cannabis use,
after accounting for study site, gender, alcohol use, and alcohol and cannabis co-use days.
Though hypothesized, we did not find evidence for an independent or additive impact of co-
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occurring same-day alcohol and cannabis use. More careful research into the combined effects of
cannabis and alcohol, especially simultaneous use, and their potential psychopharmacological
interactions is also needed on both preclinical and clinical levels. Given the mainstream
popularity of cannabis use and its perceived safety and benefits, greater communication of
potential harms to laymen and experts alike is of great need.
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Table 1. Structural MRI Acquisition: Across IDEAA Sites
ThickFrequency
TR
TI
TE FOV Flip
Time
ness
x Phase
UWM
176
1 mm 2.53 1100 3.39 256 12
256x256
8 min
McLean
150
1 mm 8.20 450 3.40 240 12
256x256
9 min
UCSD
172
1 mm 7.78 450 2.99 240 12
256x192
7 min
Notes: Structural MRI acquisition parameters by study site. Slices: Number of slices per
structural MRI scan; Thickness: Thickness per slice; TR: Repetition time; TI: Inversion time;
TE: Echo time; FOV: Field of view; Flip: Tip angle; Time: Time for whole structural scan.
Slices
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Table 2. DTI Acquisition: Across IDEAA Sites
ThickPixel
TR
TE
# b0 b value # directs
Avg
ness
spacing
UWM
60
2 mm
9300
89
7
700
48
1/1
1
McLean
60
2 mm
9300
89
7
700
48
2/2
1
UCSD
34
3 mm 10900 93.1
1
1500
61
1.9/1.9
1
Notes: DTI acquisition parameters by study site. Slices: Number of slices per structural MRI
scan; Thickness: Thickness per slice; TR: Repetition time; TE: # directs: Number of diffusion
gradients.
Slices
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Table 3. Group Demographics by Substance Use Group.
Controls
n = 92
% or
M (SD) Range

MJ
n = 33
% or
M (SD) Range

ALC
n = 27
% or
M (SD) Range

MJ+ALC
n = 39
% or
M (SD) Range

Age

19.93 (2.73)
16-25

19.96 (2.59)
16-27

21.17 (2.30)
17.25-25

19.75 (2.48)
16-26

Education

13.39 (2.52)
9-21

13.02 (1.69)
11-16

14.33 (1.78)
11-17

13.04 (2.07)
10-18

50%

24%

48%

28%

71%

76%

74%

79%

15%

12%

15%

15%

n=0

n=1

Gender*
(% Female)

Race
(% Caucasian)

Ethnicity
(% Hispanic)

Left-Handed

n=1

n=1

Stroop – Color

.57 (.67)
-2.00-2.00

.42 (.61)
-1.00-1.67

.59 (.61)
-1.33-2.00

.47 (.63)
-1.33-1.50

Stroop – Word

.74 (.74)
-1.67-2.00

.35 (.91)
-1.45-1.67

.72 (.60)
-.67-1.67

.59 (.92)
-2.33-2.18

Stroop Interference

.92 (.74)
-.67-2.33

.90 (.82)
-1.07-2.22

1.03 (.53)
-.33-1.67

.91 (.80)
-2.00-3.48

Notes: Demographic and normed Stroop performance by substance use group. Groups were not
used for analyses, but to better approximate patterns of use and to establish appropriate
covariates. M = mean, SD = standard deviation, *</=.05. **</=.01. ***</=.001
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Table 4. CO and NO Group Demographic Information.
No-CO
n = 115
% or
M (SD) Range

CO
n = 68
% or
M (SD) Range

Age

20.19 (2.68)
16-25

19.96 (2.54)
16-27

Education

13.59 (2.38)
9-21

12.99 (1.92)
10-18

47%

34%

74%

71%

12%

21%

Left-Handed
Stroop –
Color
Stroop –
Word

n=2
.58 (.62)
-2.00-2.00
.69 (.72)
-1.67-2.00

n=1
.41 (.69)
-1.33-2.00
.50 (.90)
-2.33-2.18

Stroop Interference

.98 (.68)
-.67-2.33

.81 (.83)
-2.00-2.48

Gender
(% Female)

Race
(% Caucasian)

Ethnicity
(% Hispanic)

Notes: Demographic information by co-use and no-co-use groups. These groups were not use in
any analyses, but were explored for qualitative purposes to better understand the use patterns of
those who co-use compared to those who do not. M = mean, SD = standard deviation, *</=.05.
**</=.01. ***</=.001.
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Table 5. Past Month Substance Use by Substance Use Group.

Alcohol***

Controls
n = 92
M (SD) Range

MJ
n = 33
M (SD) Range

ALC
n = 27
M (SD) Range

MJ+ALC
n = 39
M (SD) Range

4.59 (5.47)
0-19.35

7.12 (5.02)
0-17.16

41.37 (21.85)
23.57-107.42

50.88 (33.72)
21.43-167.14

.06 (.27)
21.98 (29.77)
.38 (.64)
20.74 (18.19)
0-1.94
2.36-139.91
0-1.94
2.09-90.89
.28 (.60)
.12 (.42)
3.07 (3.34)
3.85 (4.47)
Binge***
0-2.90
0-1.94
0-11.61
0-15
.04 (.21)
1.87 (2.22)
.59 (1.03)
7.26 (4.65)
Co-Use***
0-1.07
0-8.58
0-3.87
0-17.16
Co-Use.01 (.11)
.44 (.94)
.48 (.80)
3.63 (4.56)
Binge***
0-1.07
0-4.29
0-2.90
0-17.14
Notes: Past month substance use by substance group in standardized units. Groups were not used
for analyses, but to better approximate patterns of use and to establish appropriate covariates.
Alcohol: Standard drinks; 1 ounce of liquor, 4 ounces of wine, 12 ounces of beer. Cannabis:
grams. Co-Use: Co-occurring alcohol and cannabis, days of co-use. Binge: Number of binge
drinking episodes; ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by
hours. Co-Use-Binge: Co-occurring alcohol and cannabis, days of co-use-binge; binging defined
as ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by hours. M = mean,
SD = standard deviation, *</=.05. **</=.01. ***</=.001.
Cannabis***
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Table 6. CO and NO Group Past Month Substance Use Information.

Alcohol***
Cannabis***
Binge***
Co-Use***

No-CO
n = 115
M (SD) Range

CO
n = 68
M (SD) Range

9.15 (12.30)
0-61.94
.98 (3.42)
0-20.74
.49 (1.13)
0-5.81
0 (0)
0-0

37.21 (35.48)
.99-167.14
16.98 (22.40)
.08-139.91
2.99 (4.08)
0-15
4.77 (4.32)
.97-17.16

0 (0)
2.47 (3.72)
0-0
0-17.14
Notes: Past month substance use by co-use and no-co-use groups in standardized units. These
groups were not use in any analyses, but were explored for qualitative purposes to better
understand the use patterns of those who co-use compared to those who do not. Alcohol:
Standard drinks; 1 ounce of liquor, 4 ounces of wine, 12 ounces of beer. Cannabis: grams. CoUse: Co-occurring alcohol and cannabis, days of co-use. Binge: Number of binge drinking
episodes; ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by hours. CoUse-Binge: Co-occurring alcohol and cannabis, days of co-use-binge; binging defined as ≥4
drinks for females, ≥5 for males in one drinking occasion, not limited by hours. M = mean, SD =
standard deviation, *</=.05. **</=.01. ***</=.001.
Co-Use-Binge***
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Table 7. Correlations Between Substance Use Patterns.
Variables

1

1. Alcohola

-

2. Cannabisb

.30***

-

3. Co-Usec

.60***

.54***

-

4. Binged

.82***

.14

.43***

-

5. Co-Use-Bingee

.61***

.29***

.68***

.70***

-

M

19.68

8.33

1.77

1.36

.88

SD

26.75

18.14

3.50

2.85

2.51

0-167.14

0-139.91

0-17.16

0-15

0-17.14

Range

2

3

4

5

Notes: Correlations of substance use for all participants. Each variable is for past month
substance use in standard units or episodes. aPast month number of standard alcohol drinks; bpast
month number of grams of cannabis used; cpast month number of episodes using both alcohol
and cannabis, regardless of amount used; dpast month number of binge episodes (=/>4 standard
drinks for females, =/>5 standard drinks for males, on one drinking occasion); epast month
number of episodes using both binge-level alcohol and cannabis. M = mean, SD = standard
deviation, *</=.05. **</=.01. ***</=.001.
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Table 8. Demographics by Study Site.
UWM
n = 75
% or
M (SD) Range

UCSD
n = 59
% or
M (SD) Range

21.23 (2.53)
16-26
14.34 (2.17)
9-21

17.83 (.81)
16.25-19
11.20 (.76)
10-13

McLean
n = 58
% or
M (SD) Range
20.83 (2.52)
16-27
14.30 (1.70)
11-18

47%

36%

40%

68%

68%

88%

12%

27%

5%

Stroop – Color

.74 (.66)
-2.00-2.00

.18 (.65)
-1.33-1.00

.50 (.46)
-.50-1.50

Stroop – Word

.86 (.74)
-1.67-2.00
1.06 (.67)
-.67-2.00

.36 (.81)
-2.33-1.33
.51 (.76)
-2.00-2.00

.54 (.80)
-1.59-2.18
1.08 (.68)
-1.07-2.48

Age***
Education***
Gender
(% Female)

Race*
(% Caucasian)

Ethnicity **
(% Hispanic)

Stroop - Interference

Notes: Demographics and normed Stroop performance by study site. M = mean, SD = standard
deviation, *</=.05. **</=.01. ***</=.001
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Table 9. Past Month Substance Use by Study Site.
UWM
UCSD
McLean
n = 75
n = 59
n = 58
M (SD) Range
M (SD) Range
M (SD) Range
29.38 (23.44)
26.69 (2.63)
Length of Abstinence
-(Days)
5-197
12-28
3.36 (8.17)
6.70 (12.99)
16.43 (27.23)
Cannabis***
0-47.42
0-60.54
0-139.91
19.29 (26.87)
21.54 (32.82)
18.26 (18.76)
Alcohol
0-132.58
0-167.14
0-98.67
1.73 (2.96)
2.20 (3.56)
0 (0)
Binge
0-11.61
0-15
0-0
1.14 (2.73)
2.25 (3.95)
2.17 (3.87)
Co-Use
0-15.48
0-17.14
0-17.16
.44 (1.19)
2.25 (3.95)
0 (0)
Co-Use-Binge
0-5.81
0-17.14
0-0
Notes: Past month substance use by study site. Alcohol: Standard drinks; 1 ounce of liquor, 4
ounces of wine, 12 ounces of beer. Cannabis: grams. Co-Use: Co-occurring alcohol and
cannabis, days of co-use. Binge: Number of binge drinking episodes; ≥4 drinks for females, ≥5
for males in one drinking occasion, not limited by hours. Co-Use-Binge: Co-occurring alcohol
and cannabis, days of co-use-binge; binging defined as ≥4 drinks for females, ≥5 for males in
one drinking occasion, not limited by hours. M = mean, SD = standard deviation, *</=.05.
**</=.01. ***</=.001
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Table 10. Co-Use Data in FA
Tract
Forceps Major
Forceps Minor

Variable
-Cannabis

p
.03*

FDR-p
.128

Left ILF
Right ILF
Left Uncinate
Right Uncinate

Cannabis
-Cannabis
--

.017*
.011*
-

.128
.128
-

Left ATR
Right ATR
Left Cingulum
Angular Bundle

----

-

-

Right Cingulum
Angular Bundle

--

-

-

Left Cingulum
Cingulate Gyrus
Right Cingulum
Cingulate Gyrus

--

-

-

--

-

-

Left SLF Parietal

--

-

-

Right SLF Parietal
Left SLF Temporal

---

-

-

Right SLF Temporal Cannabis
.030*
.128
Multiple regression FA results for co-use data with cannabis, alcohol, and co-use cannabis and
alcohol days as primary variables; covarying for gender and study site. FDR-p = corrected for
multiple comparisons. *p<.05
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Table 11. Co-Use Data in MD.
Tract

Variable

p

FDR-p

.031*

.038*

-

-

Forceps Major

Cannabis

Forceps Minor

--

Left ILF

Cannabis

.014*

.028*

Right ILF

Cannabis

.008*

.021*

Left Uncinate

--

-

-

Right Uncinate

Cannabis

.018*

.028*

Left ATR

Cannabis

.010*

.023*

Right ATR

Cannabis

.017*

.028*

Left Cingulum
Angular Bundle

Cannabis

.033*

.038*

Right Cingulum
Angular Bundle

Cannabis

.021*

.028*

Left Cingulum
Cingulate Gyrus
Right Cingulum
Cingulate Gyrus

Cannabis

.006*

.019*

Cannabis

.021*

.028*

Left SLF Parietal

Cannabis

.005*

.019*

Right SLF Parietal

Cannabis

.001*

.008*

Left SLF Temporal

Cannabis

.003*

.016*

Right SLF Temporal
Cannabis
.001*
.008*
Multiple regression MD results for co-use data with cannabis, alcohol, and co-use cannabis and
alcohol days as primary variables; covarying for gender and study site. FDR-p = corrected for
multiple comparisons. *p<.05
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Table 12. Co-Use-Binge Data in FA
Tract
Forceps Major

Variable
--

p
-

FDR-p
-

Forceps Minor

--

-

-

Left ILF

--

-

-

Right ILF

--

-

-

Left Uncinate

--

-

-

Right Uncinate

--

-

-

Left ATR

--

-

-

Right ATR

--

-

-

Left Cingulum Angular
Bundle

--

-

-

Right Cingulum
Angular Bundle

Cannabis

.015*

.240

Left Cingulum
Cingulate Gyrus

--

-

-

Right Cingulum
Cingulate Gyrus

--

-

-

Left SLF - Parietal

--

-

-

Right SLF - Parietal

--

-

-

Left SLF - Temporal

--

-

-

Right SLF - Temp
-Multiple regression results for co-use data with cannabis, binge episodes, and co-use-binge
cannabis and binge days as primary variables; covarying for education, length of abstinence, and
study site. FDR-p = corrected for multiple comparisons. *p<.05
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Table 13. Co-Use-Binge Data in MD
Tract
Forceps Major

Variable
--

p
-

FDR-p
-

Forceps Minor

--

-

-

Left ILF

Cannabis
Co-Use-Binge

.030*
.038*

.12
.152

Right ILF
Left Uncinate

Cannabis
Co-Use-Binge
--

.044*
.02*
-

.12
.152
-

Right Uncinate

--

-

-

Left ATR

--

-

-

.045*
-

.12
-

Right ATR
Left Cingulum Angular
Bundle

Cannabis
--

Right Cingulum Angular
Bundle

--

-

-

Left Cingulum Cingulate
Gyrus

--

-

-

Right Cingulum Cingulate
Gyrus

--

-

-

Left SLF - Parietal

--

-

-

Right SLF - Parietal

Cannabis

.012*

.069

Left SLF - Temporal

Cannabis
Co-Use-Binge

.013*
.036*

.069
.152

Right SLF - Temp

Cannabis
.001*
.016*
Co-Use-Binge
.022*
.152
Multiple regression results for co-use data with cannabis, binge episodes, and co-use-binge
cannabis and binge days as primary variables; covarying for education, length of abstinence, and
study site. FDR-p = corrected for multiple comparisons. *p<.05
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Appendix: DTI values by Study Site
FA
UWM

McLean

UCSD

M (SD) Range

M (SD) Range

M (SD) Range

Forceps Major

.508 (.028) .441-.564

.559 (.060) .407-.670

.541 (.070) .354-.706

Forceps Minor

.390 (.049) .237-.539

.447 (.056) .337-.588

.426 (.071) .242-.533

Left ILF

.452 (.024) .387-.503

.489 (.043) .384-.624

.428 (.037) .228-.473

Right ILF

.459 (.026) .387-.522

.497 (.041) .405-.595

.450 (.040) .234-.519

Left Uncinate

.367 (.021) .320-.438

Right Uncinate

.369 (.021) .317-.418

.392 (.039) .317-.496

.363 (.045) .172-.430

Left ATR

.377 (.019) .337-.411

.400 (.035) .326-.486

.398 (.023) .335-.461

Right ATR

.381 (.018) .347-.427

.369 (.035) .308-.461

.424 (.030) .352-.501

Left Cingulum
Angular Bundle

.332 (.030) .264-.420

.283 (.050) .197-.437

.309 (.051) .173-.404

Right Cingulum
Angular Bundle

.334 (.036) .200-.438

.279 (.050) .175-.383

.300 (.050) .168-.396

Left Cingulum
Cingulate Gyrus
Right Cingulum
Cingulate Gyrus

.546 (.055) .386-.646

.491 (.077) .331-.730

.519 (.039) .444-.593

.502 (.046) .382-.634

.463 (.068) .331-.618

.469 (.037) .398-.551

Left SLF Parietal

.419 (.029) .350-.476

.418 (.041) .322-.506

.400 (.039) .228-.482

Right SLF Parietal

.444 (.032) .352-.530

.411 (.044) .321-.511

.420 (.032) .362-.498

Left SLF Temporal

.436 (.025) .380-.503

.454 (.038) .363-541

.415 (.051) .230-.488

Right SLF Temporal

.437 (.028) .363-.523

.413 (.040) .323-.515

.426 (.038) .253-.512

Tract
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.398 (.044) .321-.525

.345 (.053) .198-.417

MD
UWM

McLean

UCSD

M (SD) Range

M (SD) Range

M (SD) Range

Left Cingulum
Angular Bundle

.000823 (.000044)
.000742-.001060
.000901 (.000087)
.000794-.001238
.000811 (.000087)
.000748-.000886
.000814 (.000029)
.000750-.000900
.000814 (.000030)
.000738-.000877
.000812 (.000030)
.000758-.000881
.000748 (.000027)
.000696-.000809
.000755 (.000029)
.000706-.000831
.000825 (.000042)
.000703-.000905

.000871 (.000079)
.000758-.001145
.000864 (.000089)
.000756-.001183
.000847 (.000051)
.000744-.000992
.000841 (.000044)
.000761-.000954
.000867 (.000081)
.000747-.001083
.000881 (.000080)
.000772-.001087
.000843 (.000085)
.000717-.001148
.000864 (.000088)
.000724-.001133
.000936 (.000115)
.000728-.001168

.000634 (.000066)
.000552-.000887
.000651 (.000053)
.000545-.000834
.000617 (.0000386)
.000558-.000797
.000614 (.000033)
.000552-.000724
.000646 (.000043)
.000584-.000763
.000635 (.000038)
.000588-.000815
.000585 (.000028)
.000527-.000670
.000584 (.000028)
.000529-.000670
.000661 (.000049)
.000596-.000891

Right Cingulum
Angular Bundle

.000823 (.000050)
.000721-.000970

.000928 (.000115)
.000756-.001174

.000664 (.000050)
.000593-.000867

Left Cingulum
Cingulate Gyrus

.000690 (.000038)
.000605-.00792

.000863 (.000011)
.000676-.001093

.000546 (.000028)
.000492-.000635

Right Cingulum
Cingulate Gyrus

.000682 (.000038)
.000575-.000779

.000853 (.000103)
.000680-.001067

.000556 (.000030)
.000502-.000642

Left SLF Parietal

.000719 (.000026)
.000659-.000797

.000816 (.000058)
.000721-.000947

.000564 (.000031)
.000510-.000670

Right SLF Parietal

.000726 (.000026)
.000683-.000797

.000809 (.000054)
.000724-.000938

.000556 (.000023)
.000514-.000617

Left SLF Temporal

.000735 (.000026)
.000679-.000803
.000734 (.000026)
.000685-.000820

.000809 (.000056)
.000718-.000958
.000799 (.000047)
.000714-.000910

.000570 (.000038)
.000510-.000695
.000561 (.000028)
.000511-.000663

Tract
Forceps Major
Forceps Minor
Left ILF
Right ILF
Left Uncinate
Right Uncinate
Left ATR
Right ATR

Right SLF Temporal
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  use	
  and	
  FAAH	
  
genotype	
  predict	
  sleep	
  quality	
  in	
  adolescent	
  and	
  emerging	
  adults.	
  Poster	
  presented	
  at	
  
the	
  College	
  on	
  Problems	
  of	
  Drug	
  Dependence,	
  San	
  Juan,	
  Puerto	
  Rico.	
  
8. Wright,	
  N.E.,	
  Shollenbarger,	
  S.G.,	
  &	
  Lisdahl,	
  K.M.	
  (June,	
  2013).	
  	
  5-‐HTTLPR	
  genotype,	
  
gender	
  and	
  ecstasy	
  use	
  interact	
  to	
  predict	
  verbal	
  memory	
  in	
  adolescent	
  and	
  emerging	
  
adults.	
  Presented	
  at	
  The	
  International	
  Women’s	
  and	
  Children’s	
  Health	
  and	
  Gender	
  
Group,	
  San	
  Diego,	
  CA.	
  
9. Shollenbarger,	
  S.,	
  Wright,	
  N.E.,	
  Browning,	
  E.,	
  Lisdahl,	
  K.	
  (August,	
  2013).	
  Executive	
  
functioning	
  in	
  adolescent	
  and	
  emerging	
  adult	
  poly-‐substance	
  users.	
  Poster	
  presented	
  at	
  
The	
  American	
  Psychological	
  Association,	
  Honolulu,	
  HI.	
  
10. Higley,	
  A.E.,	
  Wright,	
  N.E.,	
  Tibbs,	
  J.J.,	
  Quello,	
  S.,	
  &	
  Mason,	
  B.J.	
  (June,	
  2012).	
  	
  Stress	
  and	
  
craving:	
  Predicting	
  alcohol	
  treatment	
  outcomes	
  using	
  a	
  human	
  laboratory	
  paradigm	
  of	
  
interpersonal	
  stress	
  induction.	
  Presented	
  at	
  Research	
  Society	
  on	
  Alcoholism,	
  San	
  
Francisco,	
  CA.	
  
11. Wright,	
  N.E.	
  &	
  Oakes	
  Mueller,	
  R.	
  (April,	
  2012).	
  	
  The	
  role	
  of	
  disgust	
  in	
  predicting	
  prosocial	
  
behavior.	
  	
  Presented	
  at	
  Western	
  Psychological	
  Association,	
  San	
  Francisco,	
  CA.	
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INVITED TALKS
	
  

1. Wright,	
  N.E.	
  (2016,	
  March).	
  Clinical	
  Cannabinoid	
  Gems	
  for	
  the	
  Practitioner	
  from	
  
Research	
  Data.	
  Invited	
  talk	
  to	
  the	
  pre-‐doctoral	
  Psychology	
  Interns	
  and	
  the	
  Mental	
  
Health	
  Department	
  at	
  the	
  Zablocki	
  VA	
  Medical	
  Center,	
  Milwaukee,	
  WI.	
  
2. Wright,	
  N.E.	
  (2015,	
  March).	
  Marijuana,	
  Brain	
  Development,	
  and	
  the	
  University.	
  Invited	
  
talk	
  to	
  the	
  undergraduate	
  students	
  at	
  Mount	
  Vernon	
  Nazarene	
  University,	
  Mount	
  
Vernon,	
  OH.	
  
	
  

	
  

RESEARCH EXPERIENCE
	
  

	
  

2012-‐Present	
   Graduate	
  Research	
  Assistant,	
  Brain	
  Imaging	
  and	
  Neuropsychology	
  (BraIN)	
  Lab,	
  
University	
  of	
  Wisconsin-‐Milwaukee,	
  P.I.:	
  Krista	
  Medina	
  Lisdahl,	
  Ph.D.	
  
	
  

	
  

	
  

	
  
2014-‐2017	
  
	
  

(2) Integrate	
  neuropsychological	
  and	
  psychosocial	
  data	
  across	
  five	
  sites	
  
(University	
  of	
  Wisconsin-‐Milwaukee,	
  University	
  of	
  California	
  San	
  Diego,	
  
University	
  of	
  New	
  Mexico,	
  University	
  of	
  Texas	
  Dallas,	
  and	
  Harvard	
  University)	
  
for	
  use	
  in	
  the	
  Imaging	
  Data	
  in	
  Emerging	
  Adults	
  with	
  Addiction	
  (IDEAA)	
  
Consortium.	
  	
  
Funding	
  Source:	
  R01DA030354-‐03S1,	
  NIDA;	
  P.I.s:	
  Lisdahl,	
  K.M.,	
  Gruber,	
  S.,	
  
Tapert,	
  S.,	
  &	
  	
  
Filbey,	
  F.	
  
(3) Help	
  run	
  baseline	
  data	
  collection	
  at	
  the	
  University	
  of	
  Wisconsin-‐Milwaukee	
  
site	
  in	
  the	
  Adolescent	
  Brain	
  and	
  Cognitive	
  Development	
  (ABCD)	
  study,	
  a	
  10-‐
year	
  longitudinal	
  study	
  recruiting	
  11,500	
  kids	
  at	
  approximately	
  20	
  sites	
  
across	
  the	
  country.	
  	
  
Funding	
  Source:	
  DA041025-‐01U01,	
  NIDA;	
  P.I.:	
  Lisdahl,	
  K.M.	
  
	
  

Research	
  Consultant,	
  MAPPS	
  Project,	
  University	
  of	
  Wisconsin-‐Milwaukee,	
  P.I.:	
  
Davies,	
  W.	
  Hobey	
  Davies,	
  Ph.D.	
  

	
  

Consult	
  on	
  a	
  project	
  assessing	
  the	
  feasibility	
  of	
  a	
  behavioral	
  intervention	
  parents	
  
can	
  use	
  to	
  prevent	
  the	
  initiation	
  of	
  alcohol	
  use	
  by	
  adolescents.	
  	
  

	
  

2016-‐2017	
  
	
  

(1) Assist	
  in	
  running	
  a	
  three-‐week	
  study	
  of	
  the	
  effects	
  of	
  marijuana	
  use	
  on	
  
adolescent	
  and	
  emerging	
  adult	
  brain	
  development,	
  as	
  well	
  as	
  the	
  potential	
  
influence	
  of	
  factors	
  such	
  as	
  gender,	
  alcohol	
  use,	
  life	
  stress,	
  and	
  exercise.	
  
Additional	
  longitudinal	
  effects	
  at	
  2-‐year	
  follow-‐up	
  are	
  also	
  being	
  assessed.	
  	
  
Funding	
  Source:	
  R01	
  DA030354,	
  NIDA;	
  P.I.:	
  Lisdahl,	
  K.M.	
  

Research	
  Assistant,	
  Atwater	
  Standing	
  Desks	
  Project,	
  University	
  of	
  Wisconsin-‐
Milwaukee,	
  P.I.:	
  Ann	
  Swartz,	
  Ph.D.	
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Assisted	
  in	
  a	
  year-‐long	
  study	
  of	
  in	
  a	
  community	
  elementary	
  school	
  to	
  determine	
  
possible	
  outcomes	
  of	
  standing	
  desks	
  compared	
  to	
  sitting	
  desks	
  on	
  executive	
  
function,	
  learning,	
  attention,	
  postural	
  stability,	
  and	
  physical	
  activity	
  levels.	
  	
  
	
  

	
  

2011-‐2012

Funding	
  Source:	
  SAFCO	
  Products	
  Company	
  
Research	
  Intern,	
  Laboratory	
  of	
  Clinical	
  Psychopharmacology,	
  Committee	
  on	
  the	
  
Neurobiology	
  of	
  Addictive	
  Disorders,	
  The	
  Pearson	
  Center	
  for	
  Alcoholism	
  and	
  
Addiction	
  Research,	
  The	
  Scripps	
  Research	
  Institute,	
  P.I.:	
  Barbara	
  Mason,	
  Ph.D.	
  
	
  

Assisted	
  in	
  conduction	
  of	
  12-‐week	
  long	
  clinical	
  trial	
  for	
  alcohol	
  dependence,	
  
including	
  neuropsychological	
  assessment	
  and	
  a	
  cue-‐	
  and	
  stress-‐induced	
  craving	
  
paradigm.	
  	
  
	
  

Funding	
  Source:	
  MERIT	
  Award	
  for	
  Medication	
  Development,	
  National	
  Institutes	
  
of	
  Health;	
  P.I.:	
  Mason,	
  B.J.,	
  Ph.D.	
  
TEACHING EXPERIENCE
	
  

	
  

Instructor	
  
2015-‐2016	
  
	
  

PSYCH433	
  Neuropsychology,	
  University	
  of	
  Wisconsin—Milwaukee	
  

Teaching	
  Assistant	
  
2014-‐2015	
   Graduate	
  Clinical	
  Assessment	
  Practicum,	
  University	
  of	
  Wisconsin—Milwaukee	
  
2013-‐2014	
   Psychology	
  of	
  Women	
  (PSYCH320),	
  University	
  of	
  Wisconsin—Milwaukee	
  
2012	
  
Introduction	
  to	
  Psychology	
  (PSYCH101),	
  U-‐Pace	
  Online	
  Course,	
  University	
  of	
  
Wisconsin—Milwaukee	
  
	
  

Guest	
  Lecturer	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
2016	
  
PSYCH912	
  Developmental	
  Psychopathology	
  (Graduate	
  Level).	
  Substance	
  Use	
  
Disorders.	
  University	
  of	
  Wisconsin-‐Milwaukee	
  
2016	
  
CON770	
  Psychopathology.	
  Dissociative	
  Disorders.	
  Mount	
  Mary	
  University	
  
2014	
  
PYC3500	
  Abnormal	
  Psychology.	
  	
  Substance	
  Use	
  Disorders.	
  Carthage	
  College	
  
2013	
  
PYC3500	
  Abnormal	
  Psychology.	
  	
  Substance	
  Use	
  Disorders.	
  Carthage	
  College	
  
2012-‐2013	
   PSYCH433	
  Neuropsychology.	
  Neurological	
  Disorders.	
  University	
  of	
  Wisconsin—
Milwaukee	
  
2011	
  
PSY308	
  Development	
  Psychology.	
  	
  Brain	
  Development	
  and	
  Neuroplasticity.	
  	
  Point	
  
Loma	
  Nazarene	
  University	
  
2011	
  
PSY301	
  Physiological	
  and	
  Neuropsychology.	
  Brain	
  Plasticity	
  and	
  Recovery.	
  Point	
  
Loma	
  Nazarene	
  University	
  
CLINICAL TRAINING AND EXPERIENCE
2017-‐Present	
   Psychology	
  Intern,	
  VA	
  Puget	
  Sound	
  American	
  Lake	
  
• Complete	
  three	
  4-‐month	
  rotations	
  over	
  the	
  course	
  of	
  the	
  year:	
  (1)	
  Mental	
  
Health	
  Neuropsychology,	
  with	
  a	
  CBT-‐Insomnia	
  intervention	
  minor;	
  (2)	
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Geriatric	
  Research,	
  Education,	
  and	
  Clinical	
  Care	
  (GRECC);	
  (3)	
  Residential	
  
Substance	
  Treatment.	
  
In	
  Mental	
  Health	
  Neuropsychology,	
  conducted	
  full	
  neuropsychological	
  
evaluations,	
  from	
  interview	
  through	
  feedback	
  and	
  report,	
  across	
  the	
  lifespan	
  
and	
  med-‐neuro	
  and	
  psych-‐neuro	
  referrals.	
  Additionally,	
  co-‐lead	
  a	
  CBT	
  for	
  
Insomnia	
  group.	
  
	
  

Additional	
  rotations	
  have	
  not	
  yet	
  begun	
  (GRECC:	
  December	
  18-‐April	
  6;	
  
Residential	
  Substance	
  Treatment:	
  April	
  8-‐July	
  27).	
  
	
  

2016-‐2017	
   Practicum	
  Student,	
  Medical	
  College	
  of	
  Wisconsin	
  Pediatric	
  Neuropsychology	
  
Department	
  
• Completed	
  outpatient	
  neuropsychological	
  assessments	
  with	
  children	
  
between	
  the	
  ages	
  of	
  6	
  and	
  17,	
  including	
  intake	
  interview,	
  testing,	
  report	
  
writing,	
  and	
  feedback	
  sessions.	
  
	
  

2014-‐2017	
  

Practicum	
  Student,	
  Therapy	
  Practicum	
  in	
  the	
  UWM	
  Psychology	
  Clinic	
  
• Practice	
  evidence-‐based	
  outpatient	
  treatments	
  for	
  couple’s	
  therapy	
  
(Integrative	
  Behavioral	
  Couples	
  Therapy)	
  and	
  children’s	
  anxiety	
  disorders	
  
(Coping	
  Cat)	
  with	
  members	
  of	
  the	
  community.	
  

2015-‐2016	
  

Practicum	
  Student,	
  Milwaukee	
  VA	
  Neuropsychology	
  Department	
  
• Completed	
  full	
  neuropsychological	
  assessments,	
  with	
  one	
  to	
  two	
  cases	
  seen	
  
and	
  reports	
  written	
  per	
  week.	
  Conducted	
  brief	
  cognitive	
  screenings	
  in	
  the	
  
Neurology	
  Clinic	
  and	
  participated	
  in	
  rounds	
  with	
  the	
  Neurology	
  team.	
  	
  
Peer	
  Supervisor,	
  Peer	
  Supervision	
  of	
  Assessments	
  in	
  the	
  UWM	
  Psychology	
  Clinic	
  
• Live	
  supervised	
  child	
  and	
  adult	
  learning	
  disability	
  assessment	
  sessions	
  for	
  
second	
  year	
  clinical	
  psychology	
  graduate	
  students.	
  Supervised	
  first	
  year	
  
clinical	
  psychology	
  graduate	
  student’s,	
  observing	
  clinical	
  interviews,	
  
assessments,	
  and	
  teaching	
  them	
  the	
  common	
  factors	
  of	
  therapy.	
  	
  

	
  

2014-‐2015	
  

	
  

2013-‐2014	
  

Practicum	
  Student,	
  Assessment	
  Practicum	
  in	
  the	
  UWM	
  Psychology	
  Clinic	
  
• Conducted	
  learning	
  disability	
  and	
  psychodiagnostic	
  assessments	
  using	
  a	
  
range	
  of	
  cognitive,	
  achievement,	
  and	
  neuropsychological	
  measures,	
  as	
  well	
  
as	
  symptom	
  and	
  behavioral	
  questionnaires.	
  Completed	
  clinical	
  interviews,	
  
reports,	
  and	
  feedback	
  sessions.	
  	
  
	
  
ACADEMIC AWARDS AND HONORS
	
  
	
  

2016-‐2017	
  

Distinguished	
  Dissertation	
  Fellowship,	
  a	
  competitive	
  merit-‐based	
  award	
  from	
  the	
  
University	
  of	
  Wisconsin-‐Milwaukee	
  Graduate	
  School	
  

2016	
  

Research	
  Society	
  on	
  Alcoholism	
  Student	
  Merit	
  Award,	
  for	
  the	
  2016	
  RSA	
  
Conference,	
  funded	
  by	
  the	
  National	
  Institute	
  on	
  Alcohol	
  Abuse	
  and	
  Alcoholism	
  
(NIAAA)	
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2015-‐2016	
  

Distinguished	
  Graduate	
  Student	
  Fellowship,	
  a	
  competitive	
  merit-‐based	
  award	
  
from	
  the	
  University	
  of	
  Wisconsin-‐Milwaukee	
  Graduate	
  School	
  

2015	
  

Research	
  Society	
  on	
  Alcoholism	
  Student	
  Merit	
  Award,	
  for	
  the	
  2015	
  RSA	
  
Conference,	
  funded	
  by	
  the	
  National	
  Institute	
  on	
  Alcohol	
  Abuse	
  and	
  Alcoholism	
  
(NIAAA)	
  

2013	
  

Division	
  40	
  (Clinical	
  Neuropsychology)	
  Student	
  Poster	
  Award,	
  from	
  APA	
  Division	
  
40	
  at	
  the	
  2013	
  APA	
  conference	
  

2012-‐2014	
  

Chancellor’s	
  Award,	
  recipient	
  of	
  merit-‐based	
  award	
  from	
  the	
  University	
  of	
  
Wisconsin-‐Milwaukee	
  Graduate	
  School	
  

PROFESSIONAL AFFILIATIONS AND ADDITIONAL EXPERIENCE
	
  
	
  

Intern	
  Liaison	
   Training	
  Committee,	
  VA	
  Puget	
  Sound	
  American	
  Lake,	
  2017-‐Present	
  
	
  

Reviewer	
  
	
  
	
  

PLOSOne	
  
APA	
  Graduate	
  Students	
  Science	
  Committee	
  for	
  Basic	
  Research	
  Science	
  Grants,	
  
2013-‐2014	
  

	
  
	
  
	
  
Student	
  Rep.	
   Clinical	
  Training	
  Committee,	
  University	
  of	
  Wisconsin—Milwaukee,	
  2013-‐2015	
  
	
  

AFNI	
   	
  
Bootcamp	
  	
  
	
  

Week-‐long	
  special	
  training	
  in	
  Analysis	
  of	
  Functional	
  Images	
  (AFNI)	
  at	
  the	
  National	
  	
  
Institutes	
  of	
  Health,	
  2013	
  

Professional	
   Member	
  of	
  Associate	
  of	
  Graduate	
  Students	
  in	
  Neuropsychology,	
  UWM,	
  2014-‐
2017	
  
Affiliations	
   Student	
  Member,	
  Society	
  for	
  Neuroscience,	
  2015-‐2016	
  
	
  
	
  
Student	
  Member,	
  Research	
  Society	
  on	
  Alcoholism,	
  2015-‐2016	
  
Student	
  Affiliate	
  of	
  APA,	
  2013-‐2015	
  
	
  
	
  
Student	
  Affiliate	
  of	
  APA	
  Division	
  40	
  (Clinical	
  Neuropsychology),	
  2013-‐2015	
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